comparemela.com

Latest Breaking News On - Fennec pharmaceuticals stock - Page 1 : comparemela.com

Fennec Pharmaceuticals (NASDAQ:FENC) PT Lowered to $17.00

Fennec Pharmaceuticals (NASDAQ:FENC) PT Lowered to $17.00
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United-states
Gendell-jeffrey
Adrian-haigh
Robert-andrade
Craig-hallum
Russell-investments-group-ltd
News-ratings-for-fennec-pharmaceuticals-daily
Fennec-pharmaceuticals-company-profile
Securities-exchange-commission
Fennec-pharmaceuticals-stock
Fennec-pharmaceuticals-inc
Eudaimonia-advisors

Fennec Pharmaceuticals Inc. (TSE:FRX) Director Khalid Islam Acquires 20,492 Shares

Fennec Pharmaceuticals Inc. (TSE:FRX – Get Free Report) Director Khalid Islam purchased 20,492 shares of Fennec Pharmaceuticals stock in a transaction that occurred on Thursday, November 16th. The shares were bought at an average cost of C$2.44 per share, for a total transaction of C$50,000.48. Fennec Pharmaceuticals Stock Up 2.5 % Shares of TSE:FRX opened […]

Khalid-islam
Fennec-pharmaceuticals-stock
Fennec-pharmaceuticals-inc
News-ratings-for-fennec-pharmaceuticals-daily
Fennec-pharmaceuticals
Get-free-report
Director-khalid-islam
Pharmaceuticals-inc
Fennec-pharmaceuticals-daily
Tse-frx
Frx
Medical

HC Wainwright Lowers Fennec Pharmaceuticals (NASDAQ:FENC) Price Target to $17.00

Fennec Pharmaceuticals (NASDAQ:FENC – Free Report) had its price objective trimmed by HC Wainwright from $18.00 to $17.00 in a research report report published on Friday, Marketbeat Ratings reports. The brokerage currently has a buy rating on the stock. Separately, Cantor Fitzgerald raised their price target on Fennec Pharmaceuticals from $12.00 to $16.00 and gave […]

United-states
Chrisa-rallis
Robert-andrade
Opaleye-management-inc
Analyst-recommendations-for-fennec-pharmaceuticals
Fennec-pharmaceuticals-stock
Harbert-fund-advisors-inc
Securities-exchange-commission
Fennec-pharmaceuticals
Cantor-fitzgerald
News-ratings-for-fennec-pharmaceuticals-daily
Dg-capital-management

Insider Selling: Fennec Pharmaceuticals Inc (NASDAQ:FENC) Director Sells $18,693.29 in Stock

Fennec Pharmaceuticals Inc (NASDAQ:FENC – Free Report) Director Chris A. Rallis sold 2,207 shares of the business’s stock in a transaction dated Thursday, July 6th. The stock was sold at an average price of $8.47, for a total value of $18,693.29. Following the completion of the transaction, the director now owns 28,826 shares in the […]

United-states
America
Chrisa-rallis
Jpmorgan-chase-co
News-ratings-for-fennec-pharmaceuticals-daily
Securities-exchange-commission
Quarter-for-fennec-pharmaceuticals
Institutional-trading-of-fennec-pharmaceuticals
Fennec-pharmaceuticals
Barclays-plc
Fennec-pharmaceuticals-inc

Fennec Pharmaceuticals Inc (NASDAQ:FENC) Director Chris A. Rallis Sells 1,758 Shares

Fennec Pharmaceuticals Inc (NASDAQ:FENC – Get Rating) Director Chris A. Rallis sold 1,758 shares of the company’s stock in a transaction dated Friday, May 19th. The shares were sold at an average price of $7.36, for a total transaction of $12,938.88. Following the sale, the director now owns 31,033 shares in the company, valued at […]

United-states
America
Chrisa-rallis
Cantor-fitzgerald
Citigroup-inc
Fennec-pharmaceuticals
America-corp
Hartford-financial-management-inc
Fennec-pharmaceuticals-inc
Fennec-pharmaceuticals-stock
Ancora-advisors

vimarsana © 2020. All Rights Reserved.